BAT recently acquired a 20 percent state in Organigram.Read More
Tags : british american tobacco
Organigram’s R&D and product innovation complement BAT’s plant-based expertise and development capabilities. Read More
Launched in the Manchester area, the new CBD product may later be rolled out across the U.K. Read More
The new website aims to help adult smokers and vapers make informed decisions about vaping.Read More
For many smokers, nicotine levels are an important factor in choosing a vaping product.Read More
For many of the toxicants measured, the levels were similar to those in people who stopped using tobacco.Read More
The world’s No. 2 cigarette maker is currently awaiting approval from the U.S. Food and Drug Administration to proceed with Phase 1 trials. Read More
Scientists at British American Tobacco (BAT) have proposed a new scientific framework that could be used to assess the reduced-risk potential of nicotine and tobacco products currently being developed. The new assessment framework employs a four-stage process that uses lab-based and clinical tests along with real-world observations of individual and population perception and use, according...Read More